CCR Milestones - 2021

continued Barry R. O’Keefe, Ph.D. Barry R. O’Keefe, Ph.D., has been appointed Director of and Senior Scientist in the Molecular Targets Program. Dr. O’Keefe pioneered the discovery of biotherapeutics from natural prod- ucts. He also specializes in the analysis and exploitation of protein-ligand interactions for both high-throughput screening and compound characterization. Udo Rudloff, M.D., Ph.D. Udo Rudloff, M.D., Ph.D., has been awarded tenure at NIH and appointed to Senior Investiga- tor in the Pediatric Oncology Branch. Dr. Rudloff’s work is focused on the discovery, translation and early phase clinical testing of novel therapies for patients with pancreatic and other solid organ cancers. Christina I. Schroeder, Ph.D. Christina I. Schroeder, Ph.D., has joined the Chemical Biology Laboratory as a Stadtman Tenure-Track Investigator. Her research uses bioactive peptide engineering of complex venom-derived peptides in order to investigate the therapeutic potential of ion channels upregulated in cancer. Brad St. Croix, Ph.D. Brad St. Croix, Ph.D., has been appointed as a Senior Scientist in the Mouse Cancer Genetics Program. His research focuses on the molecules involved in human tumor angiogenesis and utilizes mouse models to translate newmolecular information on angiogenesis into the development of novel diagnostics and cancer therapeutics. Travis H. Stracker, Ph.D. Travis H. Stracker, Ph.D., has been appointed as a Tenure-Track Investigator in the Radiation Oncology Branch. Dr. Stracker’s research focuses on understanding how cells respond to DNA damage and maintain genomic stability. New Faculty 28